Prediction of the early response to spironolactone in resistant hypertension by the combination of matrix metalloproteinase-9 activity and arterial stiffness parameters

被引:2
作者
Rodriguez-Sanchez, Elena [1 ]
Navarro-Garcia, Jose Alberto [1 ]
Aceves-Ripoll, Jennifer [1 ]
Gonzalez-Lafuente, Laura [1 ]
Baldan-Martin, Montserrat [2 ]
de la Cuesta, Fernando [2 ]
Alvarez-Llamas, Gloria [3 ,4 ]
Barderas, Maria G. [2 ]
Segura, Julian [1 ,5 ]
Ruilope, Luis M. [1 ,5 ,6 ,7 ]
Ruiz-Hurtado, Gema [1 ,5 ,7 ]
机构
[1] Hosp Univ 12 Octubre, Inst Res I 12, Cardiorenal Translat Lab, Madrid, Spain
[2] SESCAM, Dept Vasc Physiopathol, Hosp Nacl Paraplej HNP, Toledo, Spain
[3] IIS Fdn Jimenez Diaz UAM, Dept Immunol, Madrid, Spain
[4] REDINREN, Madrid, Spain
[5] Hosp Univ 12 Octubre, Hypertens Unit, Madrid, Spain
[6] European Univ Madrid, Madrid, Spain
[7] Hosp Univ 12 Octubre, CIBER CV, Madrid, Spain
关键词
Spironolactone; Resistant hypertension; MMP-9; Arterial stiffness; MATRIX METALLOPROTEINASES; DOUBLE-BLIND; PRESSURE; INHIBITORS; DISEASE; PLACEBO;
D O I
10.1093/ehjcvp/pvaa086
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The aim of this study was to determine whether arterial stiffness assessed with the biochemical parameter active matrix metalloproteinase (MMP)-9 and the clinical parameters pulse pressure (PP) and pulse wave velocity predicts the response to spironolactone in resistant hypertension (RH). Methods and results Ambulatory blood pressure (BP) and active MMP-9 (measured by zymography and ELISA) were measured at baseline, and patients were classified as having pseudo-RH or RH. Patients with RH received spironolactone and the response was determined after 8 weeks by ambulatory BP monitoring: those who achieved BP goals were considered controlled (CRH) and those who did not were considered uncontrolled (UCRH). Plasma active MMP-9 was significantly higher in patients with RH than with pseudo-RH, and correlated with 24 h systolic BP and PP. Receiver operating characteristic analysis indicated that active MMP-9 could predict the response to spironolactone, and its combination with 24 h PP and pulse wave velocity significantly improved this prediction. Moreover, plasma of patients with UCRH induced the MMP-9 expression pathway. Conclusion We propose active MMP-9 as a useful biomarker to identify patients with RH who will not respond to spironolactone. Combining MMP-9 activity with classical arterial stiffness parameters improves the prediction of the clinical response to spironolactone and might contribute to guide the most appropriate therapeutic decisions for patients with RH.
引用
收藏
页码:68 / 76
页数:9
相关论文
共 40 条
  • [1] Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?
    Alsharari, Reem
    Lip, Gregory Y. H.
    Shantsila, Alena
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (02) : 107 - 115
  • [2] Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
    Barbaro, Natalia Ruggeri
    Fontana, Vanessa
    Modolo, Rodrigo
    De Faria, Ana Paula
    Sabbatini, Andrea Rodrigues
    Fonseca, Francisco Helfenstein
    Anhe, Gabriel F.
    Moreno, Heitor
    [J]. BLOOD PRESSURE, 2015, 24 (01) : 7 - 13
  • [3] Metalloproteinases in metabolic syndrome
    Berg, Gabriela
    Miksztowicz, Veronica
    Schreier, Laura
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (19-20) : 1731 - 1739
  • [4] Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling
    Chen, Qishan
    Jin, Min
    Yang, Feng
    Zhu, Jianhua
    Xiao, Qingzhong
    Zhang, Li
    [J]. MEDIATORS OF INFLAMMATION, 2013, 2013
  • [5] Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring
    de la Sierra, Alejandro
    Segura, Julian
    Banegas, Jose R.
    Gorostidi, Manuel
    de la Cruz, Juan J.
    Armario, Pedro
    Oliveras, Anna
    Ruilope, Luis M.
    [J]. HYPERTENSION, 2011, 57 (05) : 898 - U74
  • [6] Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure
    Figueiredo, Valeria Nasser
    Yugar-Toledo, Juan Carlos
    Martins, Luiz Claudio
    Martins, Leandro Boer
    Cabral de Faria, Ana Paula
    Moraes, Carolina de Haro
    Sierra, Cristina
    Coca, Antonio
    Moreno, Heitor, Jr.
    [J]. BLOOD PRESSURE, 2012, 21 (01) : 31 - 38
  • [7] Circulating matrix metalloproteinases and their inhibitors in hypertension
    Fontana, Vanessa
    Silva, Pamela S.
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. CLINICA CHIMICA ACTA, 2012, 413 (7-8) : 656 - 662
  • [8] Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status
    Ghazi, Lama
    Dudenbostel, Tanja
    Lin, Chee Paul
    Oparil, Suzanne
    Calhoun, David A.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 (05) : 1005 - 1010
  • [9] Kum F, 2010, INTEGR BLOOD PRESS C, V3, P63
  • [10] Role Of MMP-2 and MMP-9 in Resistance to Drug Therapy in Patients with Resistant Hypertension
    Lacerda, Leandro
    de Faria, Ana Paula
    Fontana, Vanessa
    Moreno, Heitor
    Sandrim, Valeria
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 105 (02) : 168 - 174